ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1 

MATERIAL SUITABLE FOR DOWNLOAD

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3. 

Low-density lipoprotein cholesterol lowering and coronary plaque regression: Role of non-statin lipid-lowering therapy associated with statins

Walter Masson, Daniel Siniawski

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3. 

XIV Annual Scientific Meeting - I International Meeting Sociedad Argentina de Lípidos - International Atherosclerosis Society “Chemistry, biology, genetics: two decades”

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3. 

Bioethical aspects related to the genesis and prevention of the atherosclerotic process in childhood Silvina Cuartas, María Pérez Torre

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3. 

The digestive component in dyslipidemia of type 2 diabetes mellitus

Cecilia I. Closs, Martin A. Ruiz Diaz, Alberto Cafferata, Juan P. Nogueira

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- NO. 3. 

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

Correlation and concordance between the different lipid markers in primary prevention

Walter Masson, Daniel Siniawski, Patricia Sorroche, Emiliano Rossi

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

Triglycerides and atherosclerosis: review based on the available evidence

Pablo Corral, Macarena Sanchez Pardo

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

Familial hypercholesterolemia. Family screening from an index case

Augusto Lavalle Cobo

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

Meta-analysis of the effect of incretin on the metabolism of intestinal lipoproteins rich in triglycerides (LRT) in type 2 diabetes

Andrea Cartazzo, Juan Patricio Nogueira

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

ASCOT-LLA study: statin-related adverse events, a placebo effect?

Daniel Aymon

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 2. 

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

Influence of adiponectin on the accumulation of altered VLDL in atherogenic dyslipidemia

Laura Schreier, Diego Lucero, Verónica Miksztowicz, Carolina Olano, Michelle Bursztyn, Graciela I. López, Valeria Zagoeier, Gabriela Berg.

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

Endothelial lipase versus lipoprotein lipase: antagonistic enzymes in insulin resistance ?

Verónica Miksztowicz, Diego Lucero, Mary McCoy, Eduardo Fassio, Jeffrey Billheimer, Daniel J. Rader, Laura Schreier, Gabriela Berg.

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

PCSK9 inhibitors. Your future in the treatment of dyslipidemias

Juan Carlos Rivas

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

Retinoids and lipid profile. Description of an extreme case

Walter Mason

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

LEADER study, a lipid approach

Juan Patricio Nogueira

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1. 

Evaluation of the isolated decrease in HDL cholesterol as an atherogenic risk factor in normal weight pediatric patients

Silvina Cuartas, Maria Perez Torre, Marina Galizzi

ARGENTINE JOURNAL OF LIPIDS. YEAR 2017. VOL 1- Nº 1.